day 1 agenda

6th Global webinar on
Mar 18 - 19, 2024 (GMT- London Time) 
Meeting ID: 865 0883 2755
Passcode: 898216
10:10-10:30 Nutritional Approaches in Comperensive Clinical Trials Targeting Biological and Cognitive Function in Alzheimer Disease
 OZNUR OZGE OZCAN,  Uskudar University, Turkey
10:30-10:50 Evolution of Reasons for Living and Dying among Individuals with a History of Suicide Attempts: A Two-Year Follow-Up Investigation
Anja C. Gysin-Maillart, Translational Research Center, Switzerland
10:50-11:20 Design, Synthesis, Metal Chelation Potential and Biological Evaluation of Pyridine Chalcones as Multi-Target-Directed Ligands against Alzheimer’s Disease 
Arati Prabhu, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, India
11:20-11:50 The perceptions of different professionals on school absenteeism and the role of school health care: a focus group study conducted in Finland
Katja Melander,University of Helsinki, Finland
11:50-12:10 The function of human Oxidation Resistance 1 (OXR1) in neurodevelopmental disorders
Jing Ye, Norwegian University of Science and Technology (NTNU), Norway
12:10-12:30 The effect of age on the hearing-related quality of life in normal-hearing adults
Katrien Kestens, Ghent University, Belgium
12:30-13:00 The cognitive map of dancing bees
Randolf Menzel, Freie Universitat Berlin, Germany
13:00-13:20 Type 2 Diabetes as a risk factor for Alzheimer’s Disease: Perspective from a
Drosophila model of Tauopathy and neuroblastoma cells
Shreyasi Chatterjee, Nottingham Trent University, UK
13:20-13:40 Is there a relationship between Alzheimer’s and Periodontal disease? Comparative analysis
Daniela Torrealba-Garcia, Spain
13:40-14:00 Repurposing of gene expression data for brain research – is it possible?
Angelica Lindlof, University of Skovde, sweden
14:00-14:20 Chronic impact of cannabis to the brain GABA and glutamate system: from regions to pathway
Stephanie M Hare, University of Maryland School of Medicine, USA
14:20-14:40 An updated assessment of FPR2 receptor modulation on microglia cells isolated from adult APPNL-F/NL-F mice: the new direction in LPS-stimulated conditions
Jakub Kosma Frydrych, Maj Institute of Pharmacology PAS, Poland
14:40-15:00 Substance use treatment for American Indian and Alaska Native populations: Qualitative study of barriers and opportunities by an implementation framework
Claradina Soto, University of Southern California, USA
15:00-15:20 Relation between white matter integrity, perfusion, and processing speed in early-stage schizophrenia
Andreia V Faria, JHU, USA
15:20-15:40 Neurotrophic Factor- α1 Gene Therapy Prevents Memory Loss and Alzheimer’s Disease pathology in
3xTg-AD mice
Y. Peng Loh, National Institutes of Health, USA
15:40-16:00 Hsp90 co-chaperons regulate neurodegenerative disease-associated proteins
Umesh Jinwal, University of South Florida, USA
16:00-16:30 Epigenetic modifiers as game changers for healthy aging
Shikha Sharma, Instem, Bangalore, India
16:30-16:50 Oral medicine a viable target in dementia prevention
Anne O. Rice, Wichita State University, USA
16:50-17:10 Is it possible to prevent Alzheimer disease by inserting of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 Base editing and Prime editing technologies?
Jacques P. Tremblay, Laval university, Canada
17:10-17:30 Structural Mapping of Protein Aggregates in Live Eukaryotic Cells
Giulio Chiesa, University of Toronto, Canada
17:30-17:50 Unveiling the Genomic Landscape of Alzheimer's Disease and Progressive Supranuclear Palsy Through Large-Scale Whole Genome Sequencing Data
Wan-Ping Lee, University of Pennsylvania, USA

day 2 agenda

4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA(Virtually through Zoom)
Sep 14, 2023 (CEST -Barcelona Time)
13:50-14:10 Title: Transcriptomic Profiling reveals the key role of the HDAC1 gene in Frontotemporal Dementia
Amaan Arif, Amity University Uttar Pradesh, India
14:10-14:30 Title: Palliative care in advanced Alzheimer's disease dementia: evaluation of the answers given by caregivers to the accuracy of surprise question, as a prognostic tool.
Erika Kiyomi Yuyama ,Federal University of Uberlandia, Brazil
14:30-14:50 Title: Contributors to cognitive decline in adults
Graeme Peterson, Harvard University, USA
14:50-15:10 Title: Something New from Something Old:The Stages of Objective Memory Impairment (SOMI) System
Ellen Grober, Albert Einstein College of Medicine, USA
15:10-15:30 Title: Alzheimer’s Drugs: Beyond Antibodies 
Suren A.Tatulian, University of Central Florida, USA
15:30-15:50 Title: Natural α-galactoside- and β-glucoside-specific antibody immune complexes bound to surface O-glycoproteins of circulating platelets prevent aggregation, but dislodge at diabetic glucose levels
Karthi Sreedevi, Sree Chitra Tirunal Institute for medical sciences and technology, India
15:50-16:10 Title: Transcranial photobiomodulation to improve cognition and behavior/mood in ex-football players with possible chronic traumatic encephalopathy; improved functional connectivity and NAA levels on MRI
Margaret A. Naeser, Veterans Affairs Boston Healthcare System, Boston University School of Medicine, USA
16:10-16:30 Title: Synergistic influence of cytokine genes polymorphisms over the risk of dementia. A Multifactor Dimensionality Reduction Analysis.
Teresa Juarez-Cedillo,Mexican Social Security Institute, Mexico
16:30-17:00 Keynote: “Understanding & Curing Age-Related Neurologic Disease”
Michael Fossel,Telocyte LLC, USA
17:00-17:20 Title: DYRK1A-interacting proteins, a link between Down's syndrome and its comorbidities
Janel Nathalie,Paris City University, France
17:20-17:40 Title: What we know about recognizing older adults who are missing 
Vicki S.Gier, Mississippi State University-Meridian Campus, USA
17:40-18:00 Title: "Strategic Advance Care Planning”: a protocol that defines success as physicians/providers honoring patients’ wishes
Stanley A Terman, Caring Advocates, USA
18:00-18:20 Title: Federated Deep Learning for Detecting Alzheimer’s Disease in Multi-Cohort Brain MRI
Dimitris Stripelis, University of Southern California, USA
Day-2 Concludes